Sluiten Added to My program.
Sluiten Removed from My program.
Back Home

Bootcongres

Fri, March 28th, 2014, 11:45 - 11:55

Primary cytomegalovirus infection after liver transplantation is associated with attenuated T cell alloreactivity and lower incidence of late acute rejections

X. Shi, E.L.D. de Mare-Bredemeijer, M.J.H. van Campenhout, O. Tapirdamaz, N. Litjens, M.G.H. Betjes, R. van Gent, J. de Jonge, L.J.W. van der Laan, H.J. Metselaar, J. Kwekkeboom

Moderator(s): M. Hoogduijn en D.L. Roelen

Location(s): Breezaal

Category:

Alloreactive T cells mediate allograft rejection after liver transplantation (LTx). Cytomegalovirus (CMV) infection can induce long-lasting changes of T cell subsets in peripheral blood and is thought to generate alloreactive T cells. However the association between CMV infection and T cell alloreactivity is still controversial in LTx patients. The aim of this study is to determine the effects of CMV primary infection on circulating T cell subsets and T cell alloreactivity after LTx. We monitored the percentages of peripheral blood CD4+ and CD8+ TN (naïve),TCM (central memory), TEM (effector memory), and TEMRA (late-differentiated effector memory) in 36 patients before, and at 1 and 6 months after LTx. Frequencies of alloreactive T cells, which were defined as T cells that specifically upregulate CD137 upon allogeneic stimulation by donor or 3rd-party splenocytes, were compared between CMV primary infection patients (D+/R- with CMV viremia) and CMV naïve patients (D-/R-). As most CMV infection occurs within 3 months after LTx, we further retrospectively analyzed the cumulative incidence of clinically relevant late acute rejection (LAR, occurring more than 3 months after LTx) in our center by Kaplan-Meier method. 

Six months after LTx, we found CMV primary infection resulted in an expansion of CD8+ TEMRA (from 15% to 57%; p=0.0002) at the cost of decreased percentage of CD8+ TN (from 66% to 17%; p< 0.0001), while no difference was observed in CMV naïve patients. CD4+ TEM from CMV primary infection patients (n=14) contained lower frequencies of both donor and 3rd party-reactive T cells compared to CMV naïve patients (n=11) (donor-reactive: 2.9% and 6.3% respectively, p=0.02; 3rd party-reactive: 3.6% and 6.6% respectively, p=0.03). CD8+ T cells from CMV primary infection patients developed donor-specific hypo-responsiveness (donor-reactive: 0.38%, 3rd party-reactive: 1.00%, p=0.02), while donor and 3rd party-reactive CD8+ T cell frequencies were similar in CMV naïve patients. In the retrospective analysis, cumulative incidence of late acute rejection was significantly lower in D+/R- patients (n=119) compared to D-/R- patients (n=114) (3.4% and 14.0% respectively, p=0.01). 

In conclusion, we found primary CMV infection after LTx is associated with attenuated T cell alloreactivity and lower incidence of clinically relevant late acute rejections.